DUBLIN--(BUSINESS WIRE)--The "Nephrology and Urology Devices Market Global Briefing 2018" report has been added to ResearchAndMarkets.com's offering.
The report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
Wearable artificial kidney is a new trend shaping the nephrology and urology device market and replaces stationary hemodialysis machines. Traditionally, patients undergoing a renal replacement surgery had to be subjected to large blood cleansing machines, disabling free movement and freedom of living. In 2015, the FDA approved the clinical testing of wearable artificial kidney and in 2016, a prototype was tested in the University of Washington. The nephrology and urology devices market has been discussing the feasibility and development of artificial kidneys since more than a decade, and the future seems to be very promising as the test was successful with positive results.
Asia Pacific was the largest region in the nephrology and urology devices market in 2017, accounting for around 34% market share. North America was the second largest region accounting for around 28% market share. Africa was the smallest region accounting for around 3% market share.
Scope
- Markets Covered: Dialysis Devices, Urinary Stone Devices, Incontinence & Pelvic Organ Prolapse Devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, and Endoscopy Devices.
- Time Series: Five years historic and forecast.
- Data: Market value in $ billions.
- Data Segmentations: Regional breakdowns, market share of competitors, key sub segments.
Companies Mentioned
- Baxter International Inc.
- Fresenius Medical Care AG & Co KGaA
- Cook Group Incorporated
- B. Braun Group
- C. R. Bard Inc.
- Nxstage Medical Inc.
- Dornier MedTech Systems GmbH
- Rockwell Medical Inc
For more information about this report visit https://www.researchandmarkets.com/research/4lvt66/global_nephrology?w=4
